Edgestream Partners L.P. acquired a new stake in Innospec Inc. (NASDAQ:IOSP – Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 66,422 shares of the specialty chemicals company’s stock, valued at approximately $6,331,000.
Other hedge funds have also recently bought and sold shares of the company. Root Financial Partners LLC acquired a new stake in shares of Innospec in the 3rd quarter valued at about $30,000. Meeder Asset Management Inc. bought a new position in shares of Innospec during the 2nd quarter worth approximately $36,000. State of Wyoming bought a new stake in shares of Innospec in the third quarter worth $46,000. Farther Finance Advisors LLC grew its position in Innospec by 94.0% in the third quarter. Farther Finance Advisors LLC now owns 675 shares of the specialty chemicals company’s stock valued at $64,000 after purchasing an additional 327 shares in the last quarter. Finally, Public Employees Retirement System of Ohio acquired a new stake in Innospec in the 2nd quarter valued at $62,000. 96.64% of the stock is currently owned by institutional investors and hedge funds.
Innospec Trading Up 1.1%
NASDAQ IOSP opened at $78.86 on Thursday. Innospec Inc. has a 1-year low of $65.51 and a 1-year high of $102.00. The company has a 50 day moving average of $92.94 and a 200-day moving average of $84.51. The company has a market cap of $1.94 billion, a price-to-earnings ratio of 15.27, a PEG ratio of 3.10 and a beta of 0.88.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on IOSP. Weiss Ratings downgraded Innospec from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, November 4th. Seaport Research Partners reissued a “buy” rating and issued a $110.00 price objective on shares of Innospec in a research report on Thursday, August 6th. Zacks Research cut shares of Innospec from a “hold” rating to a “strong sell” rating in a report on Monday, November 9th. Finally, Wall Street Zen cut Innospec from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 26th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Innospec currently has a consensus rating of “Reduce”.
View Our Latest Research Report on IOSP
Insider Activity
In other Innospec news, Director Leslie Parrette bought 345 shares of the business’s stock in a transaction on Tuesday, November 10th. The stock was purchased at an average cost of $79.69 per share, for a total transaction of $27,493.05. Following the completion of the purchase, the director directly owned 7,721 shares of the company’s stock, valued at approximately $615,286.49. This trade represents a 4.68% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.45% of the company’s stock.
Innospec Company Profile
Innospec Inc. is a global specialty chemicals company that develops and manufactures products for customers in the fuels, oilfield and performance chemicals markets. Its Fuel Specialties business supplies additives for fuels and lubricants, while its Oilfield Services business provides chemical products and services used in oil and gas operations. Through its Performance Chemicals business, Innospec makes specialty ingredients for applications including personal care, home care and agriculture. Its products are used by industrial and consumer-products manufacturers around the world.
Featured Articles
- Five stocks we like better than Innospec
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
